Products
| Catalog No | Chemical Name | CAS Number | Purity | Chemical Structure |
|---|---|---|---|---|
| 2071607 | Pepstatin | 26305-03-3 | 98% Min. |  |
| Pepstatin inhibits the aspartic protease endothiapepsin. | ||||
| 2071540 | PF-477736 | 952021-60-2 | 98% Min. |  |
| PF-477736, also known as PF-00477736, is a potent CHK1 inhibitor with potential chemo | ||||
| 2071506 | PF-06869206 | 2227425-05-8 | 98% Min. |  |
| PF-06869206 is an Orally Bioavailable Selective Inhibitors of the Sodium-Phosphate Co | ||||
| 2071401 | Pimodivir ( VX-787 ) | 1629869-44-8 | 98% Min. |  |
| Pimodivir, also known as VX-787, JNJ-872, is a novel inhibitor of influenza virus rep | ||||
| 2062201 | p-Aminophenol sulfate | 85278-22-4 | 98% Min. | |
| 2062020 | 3-PHENYL-1H-PYRAZOLE-4-CARBALDEHYDE | 26033-20-5 | 96% Min. |  |
| 2061707 | Preladenant | 377727-87-2 | 98% Min. |  |
| Preladenant, also known as SCH 420814, is a potent and selective antagonist at the ad | ||||
| 2061706 | Paquinimod | 248282-01-1 | 98% Min. |  |
| Paquinimod, also known as ABR‑215757, is a S100A9 inhibitor preventing S100A9 bindi | ||||
| 2061301 | PDM-2 | 688348-25-6 | 98% Min. |  |
| PDM-2 is an analog of resveratrol acting as a potent and selective aryl hydrocarbon r | ||||
| 206701 | PU-WS13 | 1454619-14-7 | 98% Min. |  |
| PU-WS13 is a potent, Grp94-specific Hsp90 inhibitor of the purine scaffold class. PU- | ||||
| S-204148 | 2,6-Pyridinedicarboxaldehyde | 5431-44-7 | 98% Min. |  |
| S-204141 | Piperazine, 1-[(1aR,10bS)-1,1-difluoro-1,1a,6,10b-tetrahydrodibenzo[a,e]cyclopropa[c]cyclohepten-6-yl]-, hydrochloride (1:1), rel- | 312905-21-8 | 96% Min. |  |
| 193282 | PZ-2891 | 2170608-82-7 | >98% |  |
| PZ-2891 is a potent and selective, orally active Pantothenate kinase (PANK) modulator | ||||
| 31619 | PTI-428(PTI428) | 1953130-87-4 | 98% Min. |  |
| PTI-428 is a type of CFTR modulator called an amplifier. Amplifiers increase the amou | ||||
| 1932011 | PF-05085727 | 1415637-72-7 | >98% |  |
| PF-05085727 is a Potent, Selective, and Brain Penetrant Phosphodiesterase 2A Inhibito | ||||
| 193206 | Petesicatib | 1252637-35-6 | >98% |  |
| Petesicatib is a cathepsin inhibitor drug candidate. | ||||
| 193204 | Pyridone 6 | 457081-03-7 | >98% |  |
| Pyridone 6, also known CMP 6 or JAK Inhibitor I, is a pan-Janus-activated kinase inhi | ||||
| 193110 | Pretomanid | 187235-37-6 | >98% |  |
| Pretomanid, aslo known as PA-824, a bioreductive drug. PA-824 has potent in vitro act | ||||
| 192282 | PF-4136309 | 1341224-83-6 | >98% |  |
| PF-4136309, also known as INCB8761, is an orally available human chemokine receptor 2 | ||||
| 192272 | Palifosfamide | 31645-39-3 | >98% |  |
| Palifosfamide, also known as ZIO201, is a synthetic mustard compound with potential a | ||||
| 191145 | PF-06873600 | 2185857-97-8 | >98% |  |
| PF-06873600 is an orally bioavailable, cyclin-dependent kinase (CDK) inhibitor, with | ||||
| 191141 | PF04418948 | 1078166-57-0 | >98% |  |
| PF-04418948 is a novel, potent and selective prostaglandin EP2 receptor antagonist. | ||||
| 1812253 | PF74 | 1352879-65-2 | >98% |  |
| PF-3450074, also known as PF74, is a HIV-1 inhibitor that targets HIV capsid protein. | ||||
| 1812135 | PT2385 | 1672665-49-4 | >98% |  |
| PT2385 is an orally active, small molecule inhibitor of hypoxia inducible factor (HIF | ||||
| 1811232 | PF 1022A | 133413-70-4 | >98% |  |
| PF1022A is a novel anthelmintic that binds to the latrophilin-like transmembrane rece | ||||
| 1811221 | Pralatrexate | 146464-95-1 | >98% |  |
| Pralatrexate is a folate analogue inhibitor of dihydrofolate reductase (DHFR) exhibit | ||||
| 1811162 | PF-05231023 | 1037589-69-7 | >98% |  |
| PF-05231023 is a long-acting FGF21 mimetic. PF-05231023 decreases body weight and imp | ||||
| 1810254 | PA-8 | 878437-15-1 | >98% |  |
| A-8 is a small-molecule antagonist of the PAC1 receptor. | ||||
| 1810242 | Pyronaridine Tetraphosphate | 76748-86-2 | >98% |  |
| Pyronaridine Tetraphosphate is an antimalarial agent, blocking B-hematin formation, i | ||||
| 1810234 | PH-002 | 1311174-68-1 | >98% |  |
| PH-002 is a novel inhibitor of apolipoprotein (apo) E4 intramolecular domain interact | ||||